-+ 0.00%
-+ 0.00%
-+ 0.00%

*Bristol Myers Squibb: In Legacy Portfolio, Demand Increased for Eliquis in 2Q, Which Was More Than Offset by Expected Continued Generic Impacts Across Remainder of Portfolio >BMY

Dow Jones·07/30/2026 10:59:00

Please log in to view news